Literature DB >> 23599648

Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.

Barbara Dorottya Lovasz1, Laszlo Lakatos, Agnes Horvath, Istvan Szita, Tunde Pandur, Michael Mandel, Zsuzsanna Vegh, Petra Anna Golovics, Gabor Mester, Mihaly Balogh, Csaba Molnar, Erzsebet Komaromi, Lajos Sandor Kiss, Peter Laszlo Lakatos.   

Abstract

AIM: To investigate the evolution of disease phenotype in adult and pediatric onset Crohn's disease (CD) populations, diagnosed between 1977 and 2008.
METHODS: Data of 506 incident CD patients were analyzed (age at diagnosis: 28.5 years, interquartile range: 22-38 years). Both in- and outpatient records were collected prospectively with a complete clinical follow-up and comprehensively reviewed in the population-based Veszprem province database, which included incident patients diagnosed between January 1, 1977 and December 31, 2008 in adult and pediatric onset CD populations. Disease phenotype according to the Montreal classification and long-term disease course was analysed according to the age at onset in time-dependent univariate and multivariate analysis.
RESULTS: Among this population-based cohort, seventy-four (12.8%) pediatric-onset CD patients were identified (diagnosed ≤ 17 years of age). There was no significant difference in the distribution of disease behavior between pediatric (B1: 62%, B2: 15%, B3: 23%) and adult-onset CD patients (B1: 56%, B2: 21%, B3: 23%) at diagnosis, or during follow-up. Overall, the probability of developing complicated disease behaviour was 49.7% and 61.3% in the pediatric and 55.1% and 62.4% in the adult onset patients after 5- and 10-years of follow-up. Similarly, time to change in disease behaviour from non stricturing, non penetrating (B1) to complicated, stricturing or penetrating (B2/B3) disease was not significantly different between pediatric and adult onset CD in a Kaplan-Meier analysis. Calendar year of diagnosis (P = 0.04), ileal location (P < 0.001), perianal disease (P < 0.001), smoking (P = 0.038) and need for steroids (P < 0.001) were associated with presence of, or progression to, complicated disease behavior at diagnosis and during follow-up. A change in disease location was observed in 8.9% of patients and it was associated with smoking status (P = 0.01), but not with age at diagnosis.
CONCLUSION: Long-term evolution of disease behavior was not different in pediatric- and adult-onset CD patients in this population-based cohort but was associated to location, perianal disease and smoking status.

Entities:  

Keywords:  Age at diagnosis; Crohn’s disease; Disease behavior; Disease course

Mesh:

Year:  2013        PMID: 23599648      PMCID: PMC3627886          DOI: 10.3748/wjg.v19.i14.2217

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.

Authors:  Laszlo Lakatos; Lajos S Kiss; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Peter Laszlo Lakatos
Journal:  Inflamm Bowel Dis       Date:  2011-01-06       Impact factor: 5.325

Review 2.  Hospitalisations and surgery in Crohn's disease.

Authors:  Charles N Bernstein; Edward V Loftus; Siew C Ng; Peter L Lakatos; Bjorn Moum
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

3.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.

Authors:  Gert Van Assche; Axel Dignass; Julian Panes; Laurent Beaugerie; John Karagiannis; Mathieu Allez; Thomas Ochsenkühn; Tim Orchard; Gerhard Rogler; Edouard Louis; Limas Kupcinskas; Gerassimos Mantzaris; Simon Travis; Eduard Stange
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

Review 4.  Natural history of pediatric-onset inflammatory bowel disease: a systematic review.

Authors:  Bincy P Abraham; Seema Mehta; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2012-08       Impact factor: 3.062

5.  Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.

Authors:  Peter Laszlo Lakatos; Petra Anna Golovics; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Agnes Horvath; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Gabor Veres; Barbara Dorottya Lovasz; Miklos Szathmari; Lajos S Kiss; Laszlo Lakatos
Journal:  Am J Gastroenterol       Date:  2012-01-10       Impact factor: 10.864

Review 6.  New IBD genetics: common pathways with other diseases.

Authors:  C W Lees; J C Barrett; M Parkes; J Satsangi
Journal:  Gut       Date:  2011-02-07       Impact factor: 23.059

7.  Natural history of Crohn's disease: comparison between childhood- and adult-onset disease.

Authors:  Bénédicte Pigneur; Philippe Seksik; Sheila Viola; Jérôme Viala; Laurent Beaugerie; Jean-Philippe Girardet; Frank M Ruemmele; Jacques Cosnes
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

8.  Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.

Authors:  Kelly M Tarrant; Murray L Barclay; Christopher M A Frampton; Richard B Gearry
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

9.  Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.

Authors:  Peter Laszlo Lakatos; Zsofia Czegledi; Tamas Szamosi; Janos Banai; Gyula David; Ferenc Zsigmond; Tunde Pandur; Zsuzsanna Erdelyi; Orsolya Gemela; Janos Papp; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

10.  Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.

Authors:  Tamas Szamosi; Janos Banai; Laszlo Lakatos; Zsofia Czegledi; Gyula David; Ferenc Zsigmond; Tunde Pandur; Zsuzsanna Erdelyi; Orsolya Gemela; Maria Papp; Janos Papp; Peter Laszlo Lakatos
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-07       Impact factor: 2.566

View more
  14 in total

Review 1.  Redefining the IBDs using genome-scale molecular phenotyping.

Authors:  Terrence S Furey; Praveen Sethupathy; Shehzad Z Sheikh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-05       Impact factor: 46.802

2.  Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.

Authors:  Mimi C Tan; Hashem B El-Serag; Jason K Hou
Journal:  Dig Dis Sci       Date:  2016-12-23       Impact factor: 3.199

3.  Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.

Authors:  Steven F G Jeuring; Tim R A van den Heuvel; Limmie Y L Liu; Maurice P Zeegers; Wim H Hameeteman; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Ad A M Masclee; Daisy M A E Jonkers; Marieke J Pierik
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

4.  Temporal Change in Phenotypic Behaviour in Patients with Crohn's Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients?

Authors:  Rishikesh Kalaria; Devendra Desai; Philip Abraham; Anand Joshi; Tarun Gupta; Sudeep Shah
Journal:  J Crohns Colitis       Date:  2015-10-29       Impact factor: 9.071

5.  Quantitative Inflammation Assessment for Crohn Disease Using Ultrasensitive Ultrasound Microvessel Imaging: A Pilot Study.

Authors:  Ping Gong; Pengfei Song; Amy B Kolbe; Shannon P Sheedy; Chengwu Huang; Wenwu Ling; Yue Yu; Chenyun Zhou; U Wai Lok; Shanshan Tang; David H Bruining; John M Knudsen; Shigao Chen
Journal:  J Ultrasound Med       Date:  2020-04-16       Impact factor: 2.153

6.  Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.

Authors:  Daniela Simian; Daniela Fluxá; Lilian Flores; Jaime Lubascher; Patricio Ibáñez; Carolina Figueroa; Udo Kronberg; Raúl Acuña; Mauricio Moreno; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

Review 7.  Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

Authors:  Petra A Golovics; Michael D Mandel; Barbara D Lovasz; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

8.  Early-onset versus late-onset Crohn's disease: An Italian cohort study.

Authors:  Laura Cantoro; Marco Vincenzo Lenti; Rita Monterubbianesi; Michele Cicala; Diana Giannarelli; Claudio Papi; Anna Kohn; Antonio Di Sabatino
Journal:  United European Gastroenterol J       Date:  2019-06-19       Impact factor: 4.623

9.  Features and perspectives of MR enterography for pediatric Crohn disease assessment.

Authors:  Noemi Maria Giovanna Ognibene; Massimo Basile; Marco Di Maurizio; Giuseppe Petrillo; Claudio De Filippi
Journal:  Radiol Med       Date:  2016-02-02       Impact factor: 3.469

10.  Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

Authors:  Leonardo Guizzetti; Guangyong Zou; Reena Khanna; Parambir S Dulai; William J Sandborn; Vipul Jairath; Brian G Feagan
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.